Cargando…

The future of abortion is now: Mifepristone by mail and in-clinic abortion access in the United States

The COVID-19 pandemic disrupted health care delivery in all aspects of medicine, including abortion care. For 6 months, the mifepristone Risk Evaluation and Mitigation Strategy (REMS) was temporarily blocked, allowing for the remote provision of medication abortion. Remote medication abortion may be...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mark, Alice, Foster, Angel M., Perritt, Jamila
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Inc. 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9748603/ https://www.ncbi.nlm.nih.gov/pubmed/33844980 http://dx.doi.org/10.1016/j.contraception.2021.03.033

Ejemplares similares

Medication Abortion With Pharmacist Dispensing of Mifepristone
por: Grossman, Daniel, et al.
Publicado: (2021)

Comparing telemedicine to in-clinic medication abortions induced with mifepristone and misoprostol
por: Wiebe, Ellen R, et al.
Publicado: (2020)

Implementing medical abortion with mifepristone and misoprostol in Norway 1998–2013
por: Løkeland, Mette, et al.
Publicado: (2017)

The use of mifepristone in abortion associated with an increased risk of uterine leiomyomas
por: Shen, Qi, et al.
Publicado: (2017)

Clinical Efficacy and Safety Study of Mifepristone with Misoprostol Treatment in Patients with Missed Abortion
por: Zhao, Xiaoying, et al.
Publicado: (2021)

Commentary: No-test medication abortion: A sample protocol for increasing access during a pandemic and beyond()()
por: Raymond, Elizabeth G., et al.
Publicado: (2020)

Dispensing mifepristone for medical abortion in Canada: Pharmacists’ experiences of the first year
por: Zusman, Enav Z., et al.
Publicado: (2023)

Mifepristone Antagonization with Progesterone to Avert Medication Abortion: A Scoping Review
por: DeBeasi, Paul L. C.
Publicado: (2023)

Retracted: Clinical Efficacy and Safety Study of Mifepristone with Misoprostol Treatment in Patients with Missed Abortion
por: and Alternative Medicine, Evidence-Based Complementary
Publicado: (2023)

“Technically an abortion”: Understanding perceptions and definitions of abortion in the United States
por: VandeVusse, Alicia J., et al.
Publicado: (2023)

Medical abortion with mifepristone and home administration of misoprostol up to 63 days’ gestation
por: Løkeland, Mette, et al.
Publicado: (2014)

Early medical abortion with self‐administered low‐dose mifepristone in combination with misoprostol
por: Song, Li‐Ping, et al.
Publicado: (2018)

Subsequent placenta accreta after previous mifepristone-induced abortion: A case report
por: Zhao, Peng, et al.
Publicado: (2021)

Pharmacist checklist and resource guide for mifepristone medical abortion: User-centred development and testing
por: Rebic, Nevena, et al.
Publicado: (2021)

Pharmacist direct dispensing of mifepristone for medication abortion in Canada: a survey of community pharmacists
por: Zusman, Enav Z, et al.
Publicado: (2022)

The efficacy and influence factors analysis of Mifepristone combined with estrogen-progesterone in the treatment of incomplete abortion
por: Wang, Kai, et al.
Publicado: (2022)

Could implementation of mifepristone address Canada’s urban–rural abortion access disparity: a mixed-methods implementation study protocol
por: Norman, Wendy V, et al.
Publicado: (2019)

Abortion Surveillance — United States, 2019
por: Kortsmit, Katherine, et al.
Publicado: (2021)

Abortion Surveillance — United States, 2014
por: Jatlaoui, Tara C., et al.
Publicado: (2018)

Abortion Surveillance — United States, 2015
por: Jatlaoui, Tara C., et al.
Publicado: (2018)

Abortion Surveillance — United States, 2018
por: Kortsmit, Katherine, et al.
Publicado: (2020)

Abortion Surveillance — United States, 2020
por: Kortsmit, Katherine, et al.
Publicado: (2022)

Self-Managed Abortion in the United States
por: Verma, Nisha, et al.
Publicado: (2023)

Abortion Surveillance — United States, 2021
por: Kortsmit, Katherine, et al.
Publicado: (2023)

Determination of Mifepristone (RU-486) and Its Metabolites in Maternal Blood Sample after Pharmacological Abortion
por: Szpot, Paweł, et al.
Publicado: (2022)

Building infrastructures of abortion care in an un-caring state: acompañante’s carework and abortion access in Peru
por: Duffy, Deirdre, et al.
Publicado: (2023)

Shining the light on abortion: Drivers of online abortion searches across the United States in 2018
por: Guendelman, Sylvia, et al.
Publicado: (2020)

US Supreme Court upholds abortion rights, for now
por: Jaffe, Susan
Publicado: (2020)

Laws Restricting Access to Abortion Services and Infant Mortality Risk in the United States
por: Pabayo, Roman, et al.
Publicado: (2020)

The Role of Telehealth in Promoting Equitable Abortion Access in the United States: Spatial Analysis
por: Koenig, Leah R, et al.
Publicado: (2023)

The Potential of Self-Managed Abortion to Expand Abortion Access in Humanitarian Contexts
por: Jayaweera, Ruvani, et al.
Publicado: (2021)

Enabling access to quality abortion care: WHO's Abortion Care guideline
por: Kim, Caron R, et al.
Publicado: (2022)

Prior Abortions and Barriers to Abortion Access Reported by Pregnant Women Veterans
por: Judge-Golden, Colleen, et al.
Publicado: (2022)

Trends in medication abortion and the role of low-volume and nonmetropolitan mifepristone purchasers: 2008–2011 and 2014–2017()
por: Jones, Rachel K.
Publicado: (2020)

Cost of goods sold analysis and recommendations to reduce costs of co-packaged mifepristone–misoprostol for medical abortion
por: Chinery, Lester, et al.
Publicado: (2020)

Implementation of mifepristone medical abortion in Canada: pilot and feasibility testing of a survey to assess facilitators and barriers
por: Devane, Courtney, et al.
Publicado: (2019)

Estimating abortion provision and abortion referrals among United States obstetrician-gynecologists in private practice(,)
por: Desai, Sheila, et al.
Publicado: (2017)

Breast Cancer and the Politics of Abortion in the United States
por: JASEN, PATRICIA
Publicado: (2005)

Clinical Outcomes and Women’s Experiences before and after the Introduction of Mifepristone into Second-Trimester Medical Abortion Services in South Africa
por: Constant, Deborah, et al.
Publicado: (2016)

Access to later abortion in the United States during COVID-19: challenges and recommendations from providers, advocates, and researchers
por: Ruggiero, Samantha, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_gk4h57p1c0eme5ak6gehn2t2cu